Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 17 Nov 2022

β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence

in Cancer Molecular Targets and Therapeutics

Khalid Bashir Mir
Mir Mohd Faheem
Syed Mudabir Ahmad
Javeed Ur Rasool
Tanzeeba Amin
Souneek Chakraborty
Madhulika Bhagat
Zabeer Ahmed
Asif Ali
Anindya Goswami

Frontiers in Oncology

doi 10.3389/fonc.2022.1013500

3,730 views
6 citations

Review

Published on 17 Nov 2022

Utilization of macrocyclic peptides to target protein-protein interactions in cancer

in Cancer Molecular Targets and Therapeutics

Jiawen Yang
Qiaoliang Zhu
Yifan Wu
Xiaojuan Qu
Haixia Liu
Biao Jiang
Di Ge
Xiaoling Song

Frontiers in Oncology

doi 10.3389/fonc.2022.992171

8,868 views
13 citations

Review

Published on 16 Nov 2022

Impact of SOX2 function and regulation on therapy resistance in bladder cancer

in Cancer Molecular Targets and Therapeutics

Guodong Chen
Yan Chen
Ruiquan Xu
Guoxi Zhang
Xiaofeng Zou
Gengqing Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1020675

3,080 views
9 citations

Original Research

Published on 16 Nov 2022

Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines

in Cancer Molecular Targets and Therapeutics

Anna-Maria Barciszewska
Agnieszka Belter
Iwona Gawrońska
Małgorzata Giel-Pietraszuk
Mirosława Z. Naskręt-Barciszewska

Frontiers in Oncology

doi 10.3389/fonc.2022.1033035

3,246 views
13 citations

Original Research

Published on 15 Nov 2022

Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis

in Cancer Molecular Targets and Therapeutics

Dandan Jiang
Peizhi Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1057455

3,216 views
16 citations

Review

Published on 15 Nov 2022

Ferroptosis in osteosarcoma: A promising future

in Cancer Molecular Targets and Therapeutics

Xiang Liu
Shaowen Du
Shengdong Wang
Kaishan Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.1031779

4,963 views
28 citations

Review

Published on 14 Nov 2022

The role of noncoding RNAs in cancer lipid metabolism

in Cancer Molecular Targets and Therapeutics

Ye Wang
Qian Li
Song Wang
Bi-jun Wang
Yan Jin
Hao Hu
Qing-sheng Fu
Jia-wei Wang
Qing Wu
Long Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.1026257

2,763 views
9 citations

Brief Research Report

Published on 10 Nov 2022

Laparoscopic electrochemotherapy for the treatment of hepatocellular carcinoma: Technological advancement

in Cancer Molecular Targets and Therapeutics

Blaz Trotovsek
Benjamin Hadzialjevic
Maja Cemazar
Gregor Sersa
Mihajlo Djokic

Frontiers in Oncology

doi 10.3389/fonc.2022.996269

1,894 views
7 citations

Original Research

Published on 10 Nov 2022

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel

in Cancer Molecular Targets and Therapeutics

Mingyue Xia
Shuyan Wang
Yannan Qi
Kaili Long
Enjie Li
Lingfeng He
Feiyan Pan
Zhigang Guo
Zhigang Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.993243

2,908 views
11 citations

Case Report

Published on 09 Nov 2022

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report

in Cancer Molecular Targets and Therapeutics

Lucheng Zhu
Shenglin Ma
Bing Xia

Frontiers in Oncology

doi 10.3389/fonc.2022.1009076

2,654 views
7 citations

Review

Published on 07 Nov 2022

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress

in Cancer Molecular Targets and Therapeutics

Xinyuan Shen
Shengcheng Zhou
Yidong Yang
Tu Hong
Ze Xiang
Jing Zhao
Chaojie Zhu
Linghui Zeng
Lingxiao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1034842

5,654 views
29 citations

Original Research

Published on 03 Nov 2022

GZ17-6.02 kills prostate cancer cells in vitro and in vivo

in Cancer Molecular Targets and Therapeutics

Laurence Booth
Jane L. Roberts
Cameron West
Paul Dent

Frontiers in Oncology

doi 10.3389/fonc.2022.1045459

2,871 views
7 citations

Original Research

Published on 03 Nov 2022

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma

in Cancer Molecular Targets and Therapeutics

Federica Fabro
Nynke M. Kannegieter
Erik L. de Graaf
Karla Queiroz
Martine L. M. Lamfers
Anna Ressa
Sieger Leenstra

Frontiers in Oncology

doi 10.3389/fonc.2022.1012236

2,874 views
2 citations

Case Report

Published on 31 Oct 2022

ALK-R3HDM1 and EML4-ALK fusion as a mechanism of acquired resistance to gefitinib: A case report and literature review

in Cancer Molecular Targets and Therapeutics

Zhu Zeng
Tao Wang
Junjun He
Yuehong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1010084

2,039 views
4 citations

Systematic Review

Published on 31 Oct 2022

HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis

in Cancer Molecular Targets and Therapeutics

Qiang Wang
Wei Zhang
Chao Deng
Shicheng Lin
Yejiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1030825

1,865 views
3 citations

Original Research

Published on 31 Oct 2022

WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis

in Cancer Molecular Targets and Therapeutics

Yu-Bo Wei
Dong-Min Liang
Mei-Ling Zhang
You-Jie Li
Hong-Fang Sun
Qin Wang
Yan Liang
Yan-Mei Li
Ran-Ran Wang
Zhen-Lin Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1032850

3,186 views
8 citations